NFKB1 and familial pancreatic carcinoma: By suppressing p65 subunit nuclear translocation and phosphorylation at Ser536, the two NF-κB activation pathways [25, 26, 39, 40], ADI reduces chemoresistance, producing a synergism on with GEM-induced programmed cell death in PANC-1 pancreatic cancer cells.